Abstract
The relationship between hip fracture risk and opioid use remains controversial. Thus, we performed a meta-analysis to assess the risk of hip fracture among opioid users. PubMed and EMBASE were searched for studies published from the inception of the databases until June 2015. The information was extracted independently by two teams of authors. When the heterogeneity was significant, the random-effects model was used to calculate the overall pooled risk estimates. Ten studies with 697,011 patients were included in the final meta-analysis. The overall combined relative risk for the use of opioids and hip fracture was 1.54 [95 % confidence interval (CI) 1.34–1.77]. Subgroup analyses revealed sources of heterogeneity, and sensitivity analysis indicated stable results, and no publication bias was observed. This meta-analysis demonstrates that opioids significantly increase the risk of hip fracture.
Similar content being viewed by others
References
Parker MJ, Pryor GA (1993) Hip fracture management. Blackwell Scientific Publications, Oxford
Cooper C, Campion G, Melton L III (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
Shen GS, Li Y, Zhao G et al (2015) Cigarette smoking and risk of hip fracture in women: a meta-analysis of prospective cohort studies. Injury 46:1333–1340
Kanungo J, Cuevas E, Guo X et al (2012) Nicotine alters the expression of molecular markers of endocrine disruption in zebrafish. Neurosci Lett 526:133–137
Gumieiro DN, Murino Rafacho BP, Buzati Pereira BL et al (2015) Vitamin D serum levels are associated with handgrip strength but not with muscle mass or length of hospital stay after hip fracture. Nutrition 31:931–934
Teng Z, Zhu Y, Wu F et al (2015) Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies. PLoS One 10:e0128232
Stewart G, Owen M (2013) Opioids in the management of persistent non-cancer pain. Anaesth Intensive Care Med 14:533–535
Takkouche B, Montes-Martínez A, Gill SS et al (2007) Psychotropic medications and the risk of fracture. Drug Saf 30:171–184
Thorell K, Ranstad K, Midlöv P et al (2014) Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatr 14:131
Lindestrand AG, Christiansen MLS, Jantzen C et al (2015) Opioids in hip fracture patients: an analysis of mortality and post hospital opioid use. Injury 46:1341–1345
Compton WM, Volkow ND (2006) Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81:103–107
Guo Z, Wills P, Viitanen M et al (1998) Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 148:887–892
Card T, West J, Hubbard R et al (2004) Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 53:251–255
Li L, Setoguchi S, Cabral H et al (2013) Opioid use for noncancer pain and risk of fracture in adults: a nested case–control study using the general practice research database. Am J Epidemiol 178:559–569
Leach MJ, Pratt NL, Roughead EE (2015) Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study. Pharmacoepidemiol Drug Saf 6:576–582
Ensrud KE, Blackwell T, Mangione CM et al (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163:949–957
Jensen J, Nielsen L, Lyhne N et al (1991) Drugs and femoral neck fracture: a case–control study. J Intern Med 229:29–33
Higgins J, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251–253
Egger M, Smith GD, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Shorr RI, Griffin MR, Daugherty JR et al (1992) Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol 47:M111–M115
Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with the use of morphine and opiates. J Intern Med 260:76–87
Kamal-Bahl SJ, Stuart BC, Beers MH (2006) Propoxyphene use and risk for hip fractures in older adults. Am J Geriatr Pharmacother 4:219–226
Wu AM, Huang CQ, Lin ZK et al (2014) The relationship between vitamin A and risk of fracture: meta-analysis of prospective studies. J Bone Miner Res 29:2032–2039
Vuong C, Van Uum SH, O’Dell LE et al (2010) The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31:98–132
Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:354–365
Ricardo Buenaventura M, Rajive Adlaka M, Nalini Sehgal M (2008) Opioid complications and side effects. Pain Physician 11:S105–S120
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
There are no identified conflicts of interest with any of the authors.
About this article
Cite this article
Ping, F., Wang, Y., Wang, J. et al. Opioids increase hip fracture risk: a meta-analysis. J Bone Miner Metab 35, 289–297 (2017). https://doi.org/10.1007/s00774-016-0755-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-016-0755-x